Crossmark

Evaluation the reactivity of a peptide-based monoclonal antibody derived from OmpA with drug resistant pulsotypes of Acinetobacter baumannii as a potential therapeutic approach

Crossref DOI link: https://doi.org/10.1186/s12941-022-00523-5

Published Online: 2022-06-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yeganeh, Omid http://orcid.org/0000-0003-0512-7193
Shabani, Mahdi http://orcid.org/0000-0002-7084-5709
Pakzad, Parviz http://orcid.org/0000-0003-0717-2780
Mosaffa, Nariman http://orcid.org/0000-0003-1695-782X
Hashemi, Ali http://orcid.org/0000-0002-7258-5541
License Information

Text and Data Mining valid from 2022-06-30

Version of Record valid from 2022-06-30
More Information

Article History

Received: 19 April 2022

Accepted: 21 June 2022

First Online: 30 June 2022

Declarations

:

: This work was approved by the institutional research ethics committee of Islamic Azad University, Science and Research branch, Tehran, Iran (Approval ID: IR.IAU.SRB. REC. 1398. 064).

: All authors understand that the text and any pictures or videos published in the article will be freely available on the internet and may be seen by the general public. The pictures, videos and text may also appear on other websites or in print, may be translated into other languages or used for commercial purposes.

: The authors declare there are no conflicts of interest.

Document is current

Any future updates will be listed below